--- title: Gene editing, AI and the medical advances of 2026 description: Ten medical advances from this year show gene editing and AI reaching patients, though only about half of the items actually rely on those technologies.... canonical: https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs twitter:card: summary_large_image twitter:site: @dailydotdev og:type: website og:site_name: daily.dev og:title: Gene editing, AI and the medical advances of 2026 | daily.dev og:description: Ten medical advances from this year show gene editing and AI reaching patients, though only about half of the items actually rely on those technologies.... og:url: https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs og:image: https://api.daily.dev/og/posts/afvjO7KJS.png og:image:alt: Gene editing, AI and the medical advances of 2026 og:image:width: 1200 og:image:height: 630 og:locale: en --- > ## Documentation Index > Fetch the complete documentation index at: https://daily.dev/llms.txt > Use this file to discover all available pages before exploring further. # Gene editing, AI and the medical advances of 2026 **[TechCentral](https://daily.dev/sources/techcentral)** · 7 min read · 0 upvotes · 0 comments ## Summary Ten medical advances from this year show gene editing and AI reaching patients, though only about half of the items actually rely on those technologies. Revolution Medicines' pancreatic cancer pill daraxonrasib roughly doubled median survival to 13.2 months and was approved as Rasonque in August. Intellia's CRISPR drug lonvo-z cut hereditary angioedema attacks by 87% in a trial, though the FDA paused trials of another Intellia therapy after a patient died of liver damage. A Boston Consulting Group analysis found 75 AI-discovered molecules entered trials between 2015 and 2023, but no drug with both an AI-found target and AI-designed molecule has yet been approved. None of the 10 treatments is registered with South Africa's Sahpra, and Casgevy costs $2.2 million in the US. ## Full article daily.dev links to this article rather than hosting it. Read it at the original source: ## Questions this post answers ### How much did Revolution Medicines' daraxonrasib improve survival in pancreatic cancer patients? Daraxonrasib, approved by the FDA as Rasonque in August, roughly doubled median survival in a trial of 500 patients whose cancer had spread despite earlier treatment, to 13.2 months versus 6.7 months on chemotherapy. It blocks faulty RAS proteins, which the company says drive more than 90% of pancreatic cancers. _Developers tracking biotech and AI-driven drug discovery news follow results like this on daily.dev._ ### Has any drug with an AI-found target and AI-designed molecule been approved yet? No drug combining an AI-identified target and an AI-designed molecule has been approved. A Boston Consulting Group analysis counted 75 AI-discovered molecules entering human trials between 2015 and 2023, growing over 60% a year, passing early safety trials 80-90% of the time, but only four in ten succeeded in the larger phase 2 trials that test whether a drug actually works. _Anyone evaluating how far AI has actually progressed in drug discovery can follow this story on daily.dev._ ### How long did a patient survive on a gene-edited pig kidney before needing a human transplant? Tim Andrews lived a record 271 days without dialysis on a pig kidney carrying 69 genetic edits, before it was removed in October 2025 as its function declined. He received a human kidney in January, in what his hospital describes as the first pig-kidney bridge to a human transplant, a case since published in The Lancet. _Readers following gene-editing and xenotransplant breakthroughs can keep up with cases like this on daily.dev._ ## Similar posts on daily.dev - [Three technologies that will shape biotech in 2026](https://daily.dev/posts/three-technologies-that-will-shape-biotech-in-2026-yn7ve5fc7) · MIT Technology Review · 0 upvotes · 0 comments - [How AI is helping solve the labor issue in treating rare diseases](https://daily.dev/posts/how-ai-is-helping-solve-the-labor-issue-in-treating-rare-diseases-rcbudxyor) · TechCrunch · 1 upvotes · 0 comments - [AI health tech is booming. The cures are not.](https://daily.dev/posts/ai-health-tech-is-booming-the-cures-are-not--idmalxgyn) · The Next Web · 1 upvotes · 0 comments - [How AI helps scientists design the next generation of medicines](https://daily.dev/posts/how-ai-helps-scientists-design-the-next-generation-of-medicines-rsdf6xsgg) · MIT Technology Review · 0 upvotes · 0 comments --- Tags: [#healthcare](https://daily.dev/tags/healthcare), [#biotech](https://daily.dev/tags/biotech) [View this post on daily.dev](https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs) ```json {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]} {"@context":"https://schema.org","@type":"TechArticle","headline":"Gene editing, AI and the medical advances of 2026","url":"https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs"},"datePublished":"2026-11-05T12:50:06.092Z","dateModified":"2026-11-05T12:50:43.542Z","description":"Ten medical advances from this year show gene editing and AI reaching patients, though only about half of the items actually rely on those technologies....","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/82f87f39928bf57cf7cbcdd43b12604a?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/82f87f39928bf57cf7cbcdd43b12604a?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"TechCentral","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"TechCentral","logo":"https://media.daily.dev/image/upload/s--RsqLDZrL--/f_auto/v1717745297/logos/techcentral","url":"https://daily.dev/sources/techcentral"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":0},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"healthcare,biotech","timeRequired":"PT7M"} {"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"TechCentral","item":"https://daily.dev/sources/techcentral"},{"@type":"ListItem","position":3,"name":"Gene editing, AI and the medical advances of 2026"}]} {"@context":"https://schema.org","@type":"FAQPage","@id":"https://daily.dev/posts/gene-editing-ai-and-the-medical-advances-of-2026-afvjo7kjs#faq","mainEntity":[{"@type":"Question","name":"How much did Revolution Medicines' daraxonrasib improve survival in pancreatic cancer patients?","acceptedAnswer":{"@type":"Answer","text":"Daraxonrasib, approved by the FDA as Rasonque in August, roughly doubled median survival in a trial of 500 patients whose cancer had spread despite earlier treatment, to 13.2 months versus 6.7 months on chemotherapy. It blocks faulty RAS proteins, which the company says drive more than 90% of pancreatic cancers. Developers tracking biotech and AI-driven drug discovery news follow results like this on daily.dev."}},{"@type":"Question","name":"Has any drug with an AI-found target and AI-designed molecule been approved yet?","acceptedAnswer":{"@type":"Answer","text":"No drug combining an AI-identified target and an AI-designed molecule has been approved. A Boston Consulting Group analysis counted 75 AI-discovered molecules entering human trials between 2015 and 2023, growing over 60% a year, passing early safety trials 80-90% of the time, but only four in ten succeeded in the larger phase 2 trials that test whether a drug actually works. Anyone evaluating how far AI has actually progressed in drug discovery can follow this story on daily.dev."}},{"@type":"Question","name":"How long did a patient survive on a gene-edited pig kidney before needing a human transplant?","acceptedAnswer":{"@type":"Answer","text":"Tim Andrews lived a record 271 days without dialysis on a pig kidney carrying 69 genetic edits, before it was removed in October 2025 as its function declined. He received a human kidney in January, in what his hospital describes as the first pig-kidney bridge to a human transplant, a case since published in The Lancet. Readers following gene-editing and xenotransplant breakthroughs can keep up with cases like this on daily.dev."}}]} ```